ArticlePharmacogenomics2012

'Generic to genetic' transition in cardiovascular and neuropsychiatric drugs: opportunity for personalized medicine.

Jorge Duconge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.